
Investor Alert: Pomerantz Law Firm Warns Investors in Intellia Therapeutics, Inc. About Class Action Lawsuit and Important Deadlines
Class Action Lawsuit Filed Against Intellia Therapeutics: What Does This Mean for Investors and the World? NEW YORK, March 3, 2025 – In a significant development for the biotech industry, Pomerantz LLP, a renowned securities law firm, has announced the filing of a class action lawsuit against Intellia Therapeutics, Inc. (“Intellia” or the “Company”) (NASDAQ:…